Previous Article | Next Article 
Journal of Bacteriology, May 1999, p. 2902-2913, Vol. 181, No. 9
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Characterization of the Major Control Region of
Vibrio cholerae Bacteriophage K139: Immunity, Exclusion,
and Integration
Jutta
Nesper,1
Julia
Blaß,1
Michael
Fountoulakis,2 and
Joachim
Reidl1,*
Zentrum für Infektionsforschung,
Universität Würzburg, 97070 Würzburg,
Germany,1 and F. Hoffmann-La Roche
Ltd., Pharmaceutical Research-Gene Technology, Basel,
Switzerland2
Received 13 November 1998/Accepted 22 February 1999
 |
ABSTRACT |
The temperate bacteriophage K139 is highly associated with
pathogenic O1 Vibrio cholerae strains. The nucleotide
sequence of the major control region of K139 was determined. The
sequences of four (cox, cII, cI,
and int) of the six deduced open reading frames and their
gene order indicated that K139 is related to the P2 bacteriophage
family. Two genes of the lysogenic transcript from the mapped promoter
PL encode homologs to the proteins CI and Int, with deduced
functions in prophage formation and maintenance. Between the
cI and int genes, two additional genes were
identified: orf2, which has no significant similarity to
any other gene, and the formerly characterized gene glo.
Further analysis revealed that Orf2 is involved in preventing
superinfection. In a previous report, we described that mutations in
glo cause an attenuation effect in the cholera mouse model
(J. Reidl and J. J. Mekalanos, Mol. Microbiol. 18:685-701, 1995).
In this report, we present strong evidence that Glo participates in
phage exclusion. Glo was characterized to encode a 13.6-kDa periplasmic
protein which inhibits phage infection at an early step, hence
preventing reinfection of vibriophage K139 into K139 lysogenic cells.
Immediately downstream of gene int, the attP
site was identified. Upon analysis of the corresponding
attB site within the V. cholerae chromosome, it became evident that phage K139 is integrated between the flagellin genes flaA and flaC of O1 El Tor and O139
V. cholerae lysogenic strains.
 |
INTRODUCTION |
In 1992 to 1993, a new Vibrio
cholerae serogroup, designated O139, was found to be responsible
for a cholera epidemic in southern and eastern parts of India and
Bangladesh (2, 45, 51). It was also reported that this new
serogroup carries temperate bacteriophages related to the kappa family
of O1 V. cholerae bacteriophages (23). Kappa
phages appear to be widely distributed in O1 V. cholerae El
Tor and are probably synonymous with the alpha phage described by
Nicolle et al. (44), typing phage 3 (9), phage 32 (33), and probably also other phages, such as VcA-2
(21), K139 (47), and V86 (13a). Kappa
phages have thus far been classified as vibriophages with a Bradley
group A morphology and a host range restriction to V. cholerae biotype El Tor, serogroup O1 (1, 12, 57, 58).
Mainly due to a lack of further characterization, it was not possible
to define the kappa phage more precisely, e.g., based on molecular
characteristics. For example, nothing is known about the regulation of
the two developmental states, lytic development and lysogeny. For
temperate integrating Escherichia coli phages, entry into
these phases is controlled by a lysis-lysogeny transcriptional regulation system and its coordination with an integration-excision, site-specific recombinational switch. Maintenance of the stable lysogenic state is regulated, for example, by the CI repressor in phage
(25) and P186 (32). The CI repressor and
often additional regulators (e.g., the tripartite immunity system of phages P1 and P7 [22]) are expressed during
lysogeny, which in consequence will also prevent the propagation of a
superinfecting phage. This property of lysogens is called immunity.
Beside this mechanism, other proteins which also act to prevent
superinfection of the lysogenic cells by other complete mechanisms,
e.g., prevention of adsorption or phage exclusion systems, are often
expressed during lysogeny (56). For example,
Salmonella typhimurium phage 22 encodes three different
systems represented by proteins A1, SieA, and SieB (54)
which prevent superinfection by the same, related, or lytic phages.
In a recent report (47), we described K139 as a temperate
phage derived from a clinical isolate of V. cholerae
serogroup O139. Based on morphology analysis, we concluded that phage
K139 belongs to the kappa phage family and showed that this phage or highly related K139 phages were widely distributed throughout different
serogroups (O1 and O139) and biotypes (El Tor and classical) of
V. cholerae. In addition, evidence was provided that the
phage encoded an exported gene product, named Glo. This protein was expressed during the lysogenic phase, and evidence was provided that it
may encode a hypothetical virulence determinant of lysogenic V. cholerae strains.
This study was initiated to elucidate Glo's function, leading to the
preliminary result that Glo participates in phage biology. We present
data indicating that the phage-encoded glo gene product is
involved in phage exclusion. We also present the DNA sequence of the
putative lysis-lysogeny switch region of the phage. It is further shown
that phage integration occurs at a distinct locus on the V. cholerae chromosome, linked to the flagellin genes flaA and flaC in O1 El Tor and O139 V. cholerae strains.
 |
MATERIALS AND METHODS |
Bacterial strains, phages, plasmids, and media.
E.
coli LE392 (F
supF supE hsdR galK trpR metB
lacY tonA) (53) was used as the recipient strain for
construction of plasmids and overexpression of proteins. V. cholerae M799, M804, M807, M817 (27), AI1838, and MO10
(64) were all clinical isolates, whereas O395 and MAK757
(37) are defined derivatives of laboratory-adapted stocks.
Cultures were grown in Luria broth (LB), LB agar, or TB top-agar medium
(38). Unless noted otherwise, antibiotics were used at the
following concentrations for E. coli and V. cholerae, respectively: ampicillin, 100 and 50 µg/ml; kanamycin,
50 and 30 µg/ml; chloramphenicol, 1.5 µg/ml; and tetracycline, 12 and 1 µg/ml. Plasmids and phages used in this study are listed in Table 1.
Oligonucleotides.
The primers seq 1 to 18 (Fig.
1)
were used for sequencing of the phage control region. The primers used
for construction, cloning, and sequencing of the Glo expression system
and amplification of the flaA and flaC regions
were GloNcoI (5'-AACATGCCATGGTGCGATTACTACCTCTA-3'), GloPstI (5'-AACTGCAGATCTTTAAGGTTACGGACGG-3'),
JN-int (5'-CGATGGGCGTTCTGTTTCTA-3'), JN-flaA
(5'-GCTCAGACGTGGGTATGTAAT-3'), and JN-flaC
(5'-GTCTCGGAAAACCAAGCAGTT-3'). The synthetic oligonucleotide
AR6, described elsewhere (47), was used to determine the
integration sites of Tn10d-cat in the K139 phage genome.




View larger version (122K):
[in this window]
[in a new window]
|
FIG. 1.
DNA sequence of the phage K139 control region. The
deduced amino acid sequences are shown below the DNA sequence.
Oligonucleotides used for sequencing (seq 1 to 18) are indicated by
solid-line arrows, and those used for the construction of the Glo
expression system are shown as dashed-line arrows. Transcriptional and
translational relevant sites are indicated; ribosomal binding sites are
marked as S.D., and putative promoters (PL and
PR) are marked by arrows. The attP site is
underlined. Tn10d-cat insertions are indicated at bp 2031 and 2863. The mapped start site of transcription is indicated at
position 1222. Putative helix-turn-helix motifs are marked by
underlining of the amino acids comprising CII and Cox.
|
|
Plasmid constructions.
Plasmid pJBcII-int is a
pBR322 derivative containing a 3.53-kb StuI-XmnI
phage DNA fragment subcloned into the FspI site of pBR322
(Fig. 2A). The orientation of the insert
was verified by sequencing with primer seq 1. Plasmid
pJBcII-glo was generated by deletion of a 1.2-kb
BclI-SspI (located downstream on pBR322) fragment
from pJBcII-int. Deletion of a 2-kb
BglII-SspI fragment from plasmid
pJBcII-int resulted in pJBcII-orf2 (Fig. 2B).
Plasmid pTrcglo, a pTrc99A (5) derivative, was
constructed by subcloning glo as an
NcoI-PstI PCR product, generated with primers
GloNcoI and GloPstI (Fig. 1). To obtain a
functional Glo-expressing system, the second codon (Met) of the signal
sequence was modified (by primer GloNcoI) to a Val codon.
The resulting construct was verified by DNA sequencing with primers seq
10 and seq 11. pTrcglo was further modified to obtain
pTrcglokan by subcloning of a kanamycin resistance
(Kmr) gene (StuI fragment originated from
plasmid pACYC177 [48]) into the FspI site
of the bla gene. This modification was necessary to provide
a
-lactamase-negative Glo expression system for use in the lysogenic
assay. As a control plasmid, pTrckan was constructed accordingly.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Construction of the control region encoding plasmid
pJBcII-int and its derivatives. (A) Orientation of the
subcloned StuI-XmnI phage fragment in the
FspI site of pBR322. (B) Deduced ORFs of the 5,031-bp DNA
phage fragment along with the putative intergenic region and promoters
PL and PR. Filled bars indicate the
corresponding DNA fragments, subcloned on pBR322
(pJBcII-orf2, pJBcII-glo, and
pJBcII-int) and pTrckan (pTrcglokan). cm9 and cm2
indicate the locations and direction of Tn10d-cat
insertions.
|
|
DNA analytical methods, PCRs, DNA sequencing, and computer
analysis.
Chromosomal DNA of V. cholerae was prepared
as described elsewhere (37), and phage DNA preparation was
carried out according to the Qiagen lambda kit protocol. Restriction
enzyme digestion and analysis were carried out as described by Maniatis
et al. (36). PCRs were performed as described by Mullis and
Faloona (40). DNA sequencing was performed by the
dideoxynucleotide chain termination method of Sanger et al.
(50), with cycling reaction as specified by Amersham Life
Sciences. DNA separation and data collection were performed with the
automatic sequencing LiCor system (MWG Biotech GmbH). Both DNA strands
were sequenced from position 690 to the end; one single strand was
sequenced from positions 1 to 690. The glo-containing region
(bp 2848 to 3308) has been published previously (GenBank accession no.
U24280 [47]) and was resequenced. Sequence analysis
was performed with Basic Blast Search 2.0 (4) at the
National Center for Biological Information, the Genetics Computer Group
Wisconsin Package, and the promoter algorithm of Mulligan et al.
(39).
Nonradioactive primer extension analysis.
The
transcriptional start site of the PL promoter was
determined by using total RNA of lysogenic V. cholerae
MAK757 K139 cells. RNA was isolated from cells by the hot-acidic phenol
method (61). Nonradioactive primer extension analysis was
performed as described previously (3) with the
cI-specific oligonucleotide seq 5 (Fig. 1).
Enrichment of the Glo protein and generation of Glo-specific
antiserum.
Glo-overexpressing plasmid pTrcglo was
transformed into E. coli LE392 or V. cholerae
strains. Transformants were grown to an optical density at 600 nm
(OD600) of 0.5 in LB-ampicillin (100 µg/ml) and induced
with 1 mM isopropyl-
-D-thiogalactopyranoside (IPTG) for
2 h. Cells were harvested by centrifugation and washed once with
phosphate-buffered saline (pH 7.4) at 4°C. To obtain periplasmic
extracts (24), the pellet was resuspended in 30 ml of
phosphate-buffered saline containing 2 mg of polymyxin B per ml and
incubated for 10 min on ice. Cells were then centrifuged (20,000 × g, 4°C, 10 min), the supernatant was
recovered, and proteins were precipitated with 80% ammonium sulfate.
The pellet was resuspended in 2 ml of 20 mM Tris-HCl (pH 7.5) and
subsequently dialyzed for 12 h against the same buffer. This
extract was loaded on an equilibrated MonoQ column (Pharmacia). Highly
enriched Glo fraction was obtained by isocratic elution (washing the
column with 20 mM Tris-HCl [pH 7.5]). Glo samples were concentrated
by centrifugation (Centriprep 3; Amicon) and stored in protein sample buffer (20 mM Tris-HCl [pH 7.5], 10% glycerol, 1 mM dithiothreitol, 1 mM EDTA) at
80°C. The enriched Glo protein fraction from E. coli was used to generate a polyclonal rabbit antiserum (BioTrend).
Fractionation of V. cholerae cells.
Early-stationary-phase cells of 150-ml LB cultures were harvested by
centrifugation, washed, and resuspended in 10 ml of cold phosphate
buffer (10 mM, pH 7). The cells were then lysed in a French press at
1,000 lb/in2. Cell debris was removed by centrifugation
(10,000 × g, 10 min, 4°C), and the recovered
supernatant was further fractionated by centrifugation
(100,000 × g, 45 min, 4°C). The remaining
supernatant was referred to as the cytosolic extract, and the pellet
(envelope fraction) was fractionated further in inner and outer
membrane preparations as described by Aono et al. (6).
Periplasmic extract (24) was prepared from 2 ml of the same
LB culture.
Protein analysis.
Protein concentrations were determined as
described by Bradford (11), using a commercial reagent
(Bio-Rad). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE) was carried out as described by Laemmli (31).
After SDS-PAGE, proteins were detected either by staining with
Coomassie brilliant blue or by Western blot analysis (59)
using the Amersham ECL reagent. Protein masses were determined by ion
spray mass spectrometry. The samples were desalted over 0.1 µl of
POROS R2 reversed-phase matrix (Perseptive Biosystems, Framingham,
Mass.) and eluted in 1 µl of 60% methanol in 5% formic acid.
Electrospray mass spectra were acquired on an API 365 triple-quadrupole
mass spectrometer (PE-Sciex, Toronto, Ontario, Canada). The N-terminal
sequencing analysis was performed on an Applied Biosystems 494 protein sequencer.
Transposon mutagenesis of phage K139.
First, minitransposon
Tn10d-cat, encoded by pAKcat (30), was
transformed into competent MO10 cells. A single transformant was then
isolated, inoculated under transposase-inducing conditions (1 mM IPTG)
in 5 ml of LB medium, and grown for 5 to 6 h. Then, the
supernatant was collected, filtered (0.2-µm-pore-size filter; Nalgene), and used for phage transduction with reference strain MAK757.
Phage transductants were then plated onto LB agar plates supplemented
with chloramphenicol (1.5 µg/ml). Chloramphenicol-resistant (Cmr) MAK757 colonies were obtained and further
characterized as K139 lysogenic cells. From these lysogens, phage
lysates were obtained and used to isolate phage DNA. The location of
the Tn10d-cat element on the phage genome was determined by
sequencing using oligonucleotide AR6 (47).
Bacteriophage techniques.
Isolation of K139 wild-type (wt)
or mutant phages, determination of the phage titer, and identification
of lysogenic cells were performed as described previously
(47). Plaque assay analysis was done by phage titer
determination. One hundred microliters of MAK757 overnight culture and
100 µl of appropriate dilutions of phage lysates were mixed, added to
8 ml of TB top agar containing 10 mM CaCl2, and poured onto
LB agar plates; then phage titer (PFU per milliliter) was determined.
Phage K139 is not inducible by UV or chemical mutagens; therefore, the
titer of spontaneously produced phage lysate of phage
K139 was
determined. As phage donors, K139 lysogenic cells harboring
plasmids
pTrc
glokan, pTrckan, pBR322, and pJB
cII-orf2,
-
cII-glo,
and -
cII-int were used. Cells were
grown overnight or to late
stationary growth phase. Cells were then
harvested by centrifugation,
and the supernatant was filtered
(0.2-µm-pore-size filter; Nalgene).
The filtrate was referred as K139
lysate. Phage titers were determined
as described
above.
Phage lysogeny assays were performed with a K139.A
(
glo::Tn
10d-bla) or K139.cm2
(
orf2::Tn
10d-cat) phage lysate.
Overnight
cultures of reference strain MAK757, transformed with
different
plasmids or lysogenized with different phages, were diluted
1:100
in LB containing 10 mM CaCl
2 and the corresponding
antibiotics.
Then 150 µl of cells (OD
600 of 0.3) was
incubated with 150 µl
of phage lysate (10
7 to
10
8 PFU/ml) for 30 min at 37°C. Cells were diluted and
subsequently
plated onto LB agar plates containing the antibiotic
corresponding
to the plasmid used and ampicillin (50 µg/ml) or
chloramphenicol
(1.5 µg/ml) to select for lysogens formed by phage
K139.A (ampicillin
resistant [Ap
r]) or K139.cm2
(Cm
r). Viable cells were determined by plating suitable
dilutions
of the same samples under nonselective conditions. For the
Glo
overexpression experiments, MAK757 cells transformed with
pTrc
glokan
and pTrckan were grown to an OD
600 of
0.3 and induced with 1 mM
IPTG for 2 h. Cells were then diluted
and used in phage infection
assays as described
above.
Nucleotide sequence accession number.
The sequence presented
in Fig. 1 has been assigned GenBank accession no. AF125163.
 |
RESULTS |
DNA sequence analysis of the major control region of K139.
A
5,031-bp segment of DNA sequence containing the glo gene and
flanking regions was determined by sequencing both strands of the
isolated K139 phage genome. The region from bp 1 to 690 was found to be
identical with the 3' end of a more than 5-kbp DNA sequence submission
(AF008938) of V. cholerae phage V86 by Das et al.
(13a). In Fig. 1, the DNA sequence is shown together with
the six predicted open reading frames (ORFs). The region from bp 851 to
314 encodes an ORF with partial similarity (27% identity in 169 amino
acids [aa]) to the CII protein of E. coli phage P186
(26). Another ORF (bp 1174 to 964) shows similarity to the
Cox proteins of phages HP1 (17) (28% identity in 69 aa) and
S2 (33% identity in 60 aa) of Haemophilus influenzae
(53a). Finally, four ORFs are encoded in the opposite
direction. The first ORF (bp 1319 to 1967) shows 26% identity in 112 amino acids to CI of phage P186 (26) and was named
cI. Downstream of cI was found an ORF, named
orf2 (bp 1993 to 2896), encoding a deduced product with no
detectable similarity to known proteins. Base pairs 2898 to 3308 encode
the previously identified gene glo, and downstream of
glo the complete phage integrase gene int was identified (bp 3311 to 4348). The deduced amino acid sequence of the
Int protein shows consistent similarity to the superfamily of phage
integrases (7), and 36% identity to the integrases of
phages P186 and P2 (26, 67).
The putative intergenic control region, containing two promoters, is
located between
cox and
cI. Nonradioactive primer
extension
analysis (
3) was performed on the P
L
promoter (transcriptional
direction of
cI,
orf2,
glo, and
int), which resulted in the
identification
of the mRNA start site (data not shown) at position bp
1222 (Fig.
1). A possible promoter element for RNA polymerase
recognition
(

10 and

35) is shown in Fig.
1 (bp 1184 to 1189 and
1208 to
1213). Features of the putative promoter P
R
(
cox direction) and
ribosomal binding sites (
52)
are indicated in Fig.
1 (bp 1302
to 1307 and 1325 to 1330) and are
based on similarity
analysis.
Enrichment of Glo and detection of its cellular localization.
In an earlier report, we showed that a Glo-Bla fusion hybrid protein
was exported outside the cytoplasmic membrane (47). As
bacteriophages often encode exported proteins, such as extracellular enzymes (e.g., cholera toxin [63]), outer membrane
proteins (e.g., Bor of phage
[8]), lipoproteins
(e.g., Llp of phage T5 [14]), or periplasmic proteins
(e.g., Sim of phage P1 [35]), we were interested in
the cellular localization of Glo. Overexpression of glo in
V. cholerae MAK757, utilizing plasmid pTrcglo,
resulted in the production of Glo observed in periplasmic extracts
(data not shown). The Glo protein purified from E. coli
(Fig. 3A, lane 5) was used to generate
Glo-specific rabbit antiserum as described in Materials and Methods.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 3.
Cellular localization of Glo. V. cholerae
MAK757 and MAK757 K139 were cell fractionated. (A) SDS-polyacrylamide
gels (15%) stained with Coomassie brilliant blue. (B) Corresponding
Western blots after reaction with a Glo-specific polyclonal rabbit
antiserum. Lanes 1 to 4, cytoplasmic, inner membrane, periplasmic, and
outer membrane extracts, respectively; lane 5, purified Glo protein;
lane S, 10-kDa molecular mass ladder (Gibco-Life Technologies); lane M,
Kaleidoscope polypeptide standard (Bio-Rad). Sizes are indicated in
kilodaltons.
|
|
Using the Glo-specific antiserum, it was possible to detect the Glo
protein in K139 lysogenic wt
V. cholerae cells. Cell
fractionation
of
V. cholerae strains MAK757 K139 and MAK757
into membrane and
soluble fractions was performed. Subsequent Western
blot analysis
using a preadsorbed Glo-specific antiserum revealed that
the Glo
protein was located in the periplasm (Fig.
3B, lane 3, MAK757
K139), with no Glo detectable in the supernatant (data not shown).
The
same result was obtained with the natural K139 lysogenic strain
MO10 in
cell fractionation experiments (data not
shown).
To identify any posttranscriptional modifications, the purified protein
was subjected to automated protein sequencing and
ion spray mass
spectrometry. The N'-terminal sequence of the mature
protein was found
to be STD(X)EKA. Therefore, a signal sequence
is encoded by aa 1 to 17, with a cleavage site of the precursor
protein between aa A17 and S18
(Fig.
1). The theoretical molecular
mass of the mature Glo protein is
13,650 Da, calculated with the
Genetics Computer Group Wisconsin
Package. This value is in agreement
with the experimentally determined
mass of 13,648 Da, and therefore
mature Glo seems to be
unmodified.
Phenotypic characterization of phage-encoded genes involved in
immunity and exclusion.
To characterize the function of the
phage-encoded genes cI, orf2, and glo,
spontaneous phage release was determined and superinfection experiments
(survival and a lysogeny plating and plaque assay) were established. To
use Cmr-selectable challenge phages, Tn10d-cat
insertions were generated in the K139 phage genome (see Materials and
Methods). The Tn10d-cat transposon is believed not to
contain any promoters in the flanking IS10 elements of 29 bp
(47). However, this element encodes the cat gene
associated promoter along with the cat gene without
transcriptional termination elements (30). Two
Tn10d-cat insertions were found to be located within and
transcribed divergently from orf2 (Fig. 2). One isolate,
phage K139.cm9 (orf2::Tn10d-cat,
inserted at bp 2081 [Fig. 1]), showed increased lytic activity
(clear, larger plaques) and drastically decreased ability to form
lysogenic colonies. We interpret this phenotype as produced by the
promoter activity of the cat promoter, which may interfere
with cI transcription, resulting in cI antisense
RNA production, or alternatively caused by an artificial activation of
PR. However, additional mutations may also contribute to
this phenotype. We have chosen this phage as a lytic challenger phage
to investigate the protection effect of Glo and Orf2, since there was
no evidence that phage K139.cm9 acted differently than the wt phage in
the initial infection process (adsorption and infection of DNA).
Another isolate, phage K139.cm2 (orf2::Tn10d-cat, inserted at bp 2863 [Fig. 1]), and the previously isolated phage K139.A
(glo::Tn10d-bla) (47) showed
moderate lytic activity, corresponding with the wt phage activity (data not shown). Both antibiotic resistance-converting phages were used to
determine lysogenic colonies.
Strong evidence for a phage-specific function of the periplasmic
protein Glo was found and suggests its participation in phage
exclusion. A first indication of a Glo-mediated protective effect
was
obtained in survival assays using the lytic phage K139.cm9.
While
reference strain MAK757 transformed with the control plasmid
was killed
by K139.cm9 (not observed with wt phage), Glo-expressing
cells were
viable (Table
2). To further address
Glo's function
in prevention of the phage infection process, we
investigated
the formation of lysogens and plaques. Expressing Glo from
plasmid
pTrc
glokan caused 16-fold (uninduced) and 166-fold
(IPTG-induced)
reductions of lysogen formation (Table
3) compared with
MAK757
transformed with control plasmid pTrckan. A similar reduction
(sevenfold, uninduced [Table
3]) of plaque formation was observed
with the lytic phage K139.cm9. These plaques exhibited changed
morphology (turbid and smaller). It was subsequently shown that
wt
phage K139 in such experiments did not allow the monitoring
of plaques
in Glo-expressing cells.
More evidence of Glo's function was obtained in additional
experiments. Reduction of lysogeny was observed when
glo was
encoded
together with
cI and
orf2
(pJB
cII-int [Table
3]).
Furthermore,
a
glo mutation in strain MAK757 K139
glo::Tn
10d-bla showed an
increased
level of being lysogenized by challenge phage K139.cm2
(Table
3)
compared with K139 wt lysogenic cells. These
glo lysogenic
cells also allowed challenge phage K139.cm9 to produce plaques,
which
was not observed with lysogenic strain MAK757 K139 as the
recipient
strain. Both
glo mutant phenotypes, (i) the increased
level
of plaque formation and (ii) the increased amount of lysogeny
formation
of the superinfecting challenge phages, could be complemented
by a
plasmid expressing Glo (Table
3). To exclude that Glo is
involved in
lysis control or phage maturation, the spontaneous
release of phage
K139 from cells expressing a plasmid encoding
glo was
determined. In these experiments, similar lysis rates
were observed in
cells expressing Glo from pTrc
glokan (under noninduced
and
induced conditions) and cells harboring control plasmids (data
not
shown).
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Protection effect versus superinfecting phage in the
presence of cI, orf2, and glo and
determination of lysogeny and plaque formationa
|
|
In contrast, spontaneous K139 phage release in CI-expressing cells
(pJB
cII-orf2) was found to be about 23-fold lower than
in
control plasmid-harboring cells (data not shown). Furthermore,
no
plaques were detected in recipient cells encoding
cI from
plasmid
pJB
cII-orf2 (Fig.
2) and challenged with wt phage
K139 (data not
shown). Both observations are in agreement with the
function of
the transcriptional regulator protein CI repressor of phage
P186
(
15), to which K139 CI shows considerable similarity.
However,
in lysogeny plating assays using phage K139.A as a challenge
phage,
the formation of Ap
r lysogenic colonies was reduced
about 100-fold in the presence
of CI (Table
3). This effect might be
the result of a feedback
inhibition on the expression of the
int gene, due to higher
cI copy numbers
(pJB
cII-orf2). By challenging strain MAK757
pJB
cII-orf2 with the highly lytic phage K139.cm9, plaque
formation was no
longer prevented, but plaques appeared smaller. This
finding indicates
that the lytic development of this superinfecting
phage could
not be effectively repressed by the CI repressor, as
explained
above.
The Orf2 phenotype was also assumed to be involved in preventing
superinfection. It was shown that if
cI and
orf2
were present
on plasmids (pJB
cII-glo [Fig.
2]), no plaques
were observed upon
challenge with the wt phage or with phage K139.cm9
(Table
3).
Also, the formation of lysogeny was reduced in cells
expressing
orf2 (pJB
cII-glo) compared with MAK757
pJB
cII-orf2 (Table
3).
Analysis of the spontaneous release
of phage K139 in
cI and
orf2-expressing
cells
(pJB
cII-glo) showed the same effect as seen with
cI-expressing
cells (pJB
cII-orf2) (data not
shown), indicating that
orf2 does
not interfere with phage
induction or maturation
processes.
Site-specific integration of phage K139 and characterization of the
att site.
The first indication about the location of
the attP site came from previous DNA hybridization
experiments (47). In these analyses, the attP
site was predicted to be located downstream of the int gene.
DNA comparison of this region (bp 4348 to 5031) with the GenBank
library resulted in the identification of a 24-bp sequence which is
also found in a region located between the flagellin genes
flaA and flaC of V. cholerae
(29). To determine whether this region might be the
attB site, the synthetic primers JN-flaA, JN-flaC and JN-int
(Fig. 4A) were designed to amplify
specific fragments consisting of the host attB or phage host
attL site. Investigation of different strains revealed the
presence of two types of PCR fragments indicating the absence or
presence of integrated phage K139 between flaA and
flaC. A 0.9-kb chromosomal phage junction PCR fragment was
synthesized with JN-int and JN-flaA primers, indicating the integration
of phage K139. A 0.5-kb chromosomal DNA PCR fragment was produced by
JN-flaA and JN-flaC primers (Fig. 4A) if no phage was integrated. The
0.9-kb PCR fragments from two lysogenic strains were sequenced with
primer seq 14 (Fig. 1). As a result, the predicted formation of the
sequence structure int-attL-flaA was obtained. Subsequently,
a typical dyad symmetry-structured att site (13)
was identified as GAAANNG6CNNTTTTC, also seen in Fig. 1 (bp
4557 to 4579).

View larger version (51K):
[in this window]
[in a new window]
|
FIG. 4.
Identification of the phage and bacterial attachment
site. (A) Chromosomal organization of integrated phage K139 between
flaA and flaC and locations of the primers. Also
indicated are the orientations of phage-harbored int and
glo genes, attL and attR, and the PCR
products expected from the primer combinations a (JN-flaA/JN-flaC) and
b (JN-flaA/JN-int). (B) A 0.7% agarose gel shows the PCR products
generated with primer combinations a and b. Lane S, 1-kb ladder DNA
standard (Gibco Life Technologies); lane 1, classical O1 V. cholerae strain O395; lanes 2 to 7, O1 El Tor V. cholerae strains MAK757, MAK757 K139, M799, M804, M807, and M817,
respectively; lanes 8 and 9, O139 V. cholerae strains AI1838
and MO10, respectively. PCR was performed for 30 cycles of 94°C for 1 min, 60°C for 1 min, and 72°C for 2 min.
|
|
In addition, several pathogenic O1
V. cholerae strains
(M799, M804, M807, and M817) isolated from different time points and
regions of cholera epidemics (
27) were investigated for K139
lysogeny (Table
4). It was shown that
these strains, including
O139 (MO10) (
64) and lysogenized
MAK757 K139, were phage productive,
immune to K139 infection, and
positive for
glo in PCR (data not
shown) and Western blot
(data not shown) analyses. Furthermore,
the phage in these strains was
found to be integrated at the
attB site within the flagellin
gene cluster (Fig.
4B). However, probably
due to spontaneous phage
curing, both PCR fragments (0.5 and 0.9
kbp) can be observed for
several strains (Fig.
4B). O1 strain
MAK757 and O139 strain AI1838
(
64), previously described as
not associated with K139
(
47), were used as controls. In addition,
classical O1
strain O395 (
37) was found to be phage resistant,
and
glo+, but no phage production was observed.
These results and results
obtained earlier (
21,
47) indicate
that classical strain O395
harbors a defective kappa prophage variant
which was not found
to be integrated between the flagellin genes (Fig.
4B).
 |
DISCUSSION |
In this report, we present data addressing the characterization of
genes which are encoded in the major control region of V. cholerae phage K139. This region was also characterized by sequencing, and it was found that the deduced ORFs and gene order showed significant similarities to the phage P2 family (10). In Fig. 5, this region is aligned to the
lysogeny-lysis switch (major control) region of temperate phages P186
(26), HP1 (17), and TP-J34 (43).
Similar to P186 and HP1, K139 contains divergently encoded lytic and
lysogenic operons that appear to be transcribed from oppositely located
promoters (PL and PR). In the transcriptional direction of the putative lytic promoter (PR), homologs of
genes cox/apl and cII are encoded. Both Cox (HP1)
and Apl (P186) have dual roles in prophage induction, acting directly
in prophage excision and in repression of CI transcription from
PL during prophage induction (18, 19, 46). The
cII gene product of P186 is required for the establishment
of lysogeny (42). K139 Cox and CII show some amino acid
similarity to H. influenzae phage HP1 (Cox) and E. coli phage P186 (CII) and may therefore have analogous functions,
which remains to be established experimentally. In addition, both
putative proteins CII and Cox contain a weak helix-turn-helix motif in
the N-terminal portion with SD scores (scores expressed in standard
deviation units relative to the appropriate mean) of 3.15 and 2.48, respectively (16) (Fig. 1). This indicates that these
proteins, like their homologs in phages P186 and HP1, may be
DNA-binding proteins (14a).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 5.
Comparison of the major control regions of different
phages. Sequence similarity between phages K139 of V. cholerae, HP1 of H. influenzae, and P186 of E. coli are indicated for the ORFs CII, Cox, CI, and Int as black
arrows; light arrows show the corresponding genes for TP-J34 and HP1
without detectable sequence similarity. SS (black boxes), signal
sequence which can also be found in Orf142 of phage TP-J34, encoding a
putative lipoprotein (43); attP, phage attachment
site; PL and PR, locations of promoter
structures.
|
|
In the lysogenic state, transcription of the genes cI,
orf2, glo, and int is probably
initiated by the mapped promoter PL. The proximal ORF of
the PL transcript, CI, is representing the putative CI
repressor, since it shares similarity with P186 CI (26).
Given the demonstrated phenotype of preventing superinfection and
hindering spontaneous phage release, it seems reasonable to speculate
that cI encodes the repressor responsible for controlling lytic development. However, the proposed function remains to be tested
experimentally. The promoter-distal ORF in this region is the
int gene, which shows consistent homology to phage
integrases (7).
Two remaining genes (orf2 and glo) were found
between cI and int. Orf2 showed no significant
similarity to other proteins, whereas Glo harbors some features also
found in eukaryotic G proteins, as reported earlier (47).
However, in phages HP1 and TP-J34 (Fig. 5), additional ORFs of unknown
function can be found between cI and int. Because
of the position of orf2 and glo within two conserved functional phage gene products (cI and
int), we investigated the involvement of these proteins in
preventing superinfection. The results indicate that Orf2 helps to
protect a lysogenic cell against superinfecting K139 phages. However,
evidence that Glo is involved in hindering phage infection processes
was also presented.
Certain phage-encoded resistance mechanisms are known to abort
infection at an early step. Proteins which alter the cell surface in
lysogenic strains and prevent adsorption to the phage receptor, a
process known as lysogenic conversion, have been identified (54,
62). Other phage proteins are known to act in superinfection exclusion, by inhibiting the DNA transfer from the adsorbed phage particle into the cytoplasm. Examples of gene products which are involved in superinfection exclusion are represented by SieA (54, 55) and Sim (28) of temperate phages P22 and P1 and by
Imm and Sp of the lytic phage T4 (34). Our investigations
suggest that the Glo protein of phage K139 may exclude superinfecting phages either by superinfection exclusion or lysogenic conversion. Several facts account for that assumption. First, data from a combination of protein and cell fractionation analyses indicated that
Glo is an exported protein, localized as a soluble protein in the
periplasm. Therefore, we speculate that the exclusion function of Glo
may be based on protein-protein interaction with yet unidentified targets or may be membrane associated. Second, plaque and lysogeny formation after superinfection with challenge phages was significantly reduced in the presence of Glo expressed from a plasmid. Consequently, a missing glo function in a lysogenic cell allowed increased
plaque and lysogeny formation after superinfection with the challenge phage. This effect could be complemented in trans by a
plasmid-encoded glo gene. Third, in killing experiments
using K139.cm9, it was shown that Glo-expressing cells were
significantly protected. Fourth, in contrast to cI-harboring
plasmids, the glo-harboring plasmid did not interfere with
phage induction or lysis control, as demonstrated by the quantification
of spontaneously released phage particles. In future analyses, we will
investigate the molecular basis of the predicted exclusion function of
the Glo protein. A comparison of the gene region between cI
and int with the corresponding regions of other temperate
phages (Fig. 5) suggests that the other unassigned ORFs on such phages
may also be associated with functions related to immunity and exclusion.
Previous analysis suggested a participation of Glo in O1 V. cholerae virulence in the infant mice assay (47). Our
results presented here shed new light on Glo's function, suggesting
that Glo encodes a soluble periplasmic protein involved in phage
exclusion. One explanation for the observed attenuated virulence
phenotype of glo lysogenic V. cholerae cells may
be that an elevated superinfection susceptibility led to a decreased
viable V. cholerae cell number. However, we cannot exclude
the possibility that Glo is released from the periplasm, for example,
during phage-mediated cell lysis, allowing a direct interaction with
host tissues. Recently, phage lysis was proposed as a plausible
releasing mechanism for Shiga toxin Stx-I or Stx-II in an H-19B
lysogenic E. coli strain (41). Future studies
will investigate whether the glo-associated virulence effect
is caused indirectly by a phage exclusion function or by direct
interaction of the Glo protein with the host systems. Other phage-specific proteins which seem to be involved in both phage viability and virulence are known. For example, Ace of phage CTXØ is a
minor coat protein (63) as well as an enterotoxin
(60). Another example is represented by a
Salmonella phage P22-encoded enzyme, which is responsible
for alteration of the lipopolysaccharide structure, preventing phage
adsorption and hence altering the antigenic properties (54,
66).
A 24-bp attP core site was found to be located in the distal
part of the int gene. The corresponding attB site
in the V. cholerae chromosome was found to be located in a
noncoding region between the flagellin genes flaA and
flaC. Recently, Klose and Mekalanos (29)
presented sequence data identifying a transposon located downstream of
the flaC region in O1 classical V. cholerae
strains. Motility contributes to the virulence of V. cholerae (20); thus, one can speculate that the
fla genes have been acquired by horizontal gene transfer,
e.g., by phage transduction or conjugative transposons. Investigating
several K139 lysogenic El Tor isolates, we always found K139 integrated
into the flaAC region but not in an O1 classical isolate.
Besides the specific characterizations of the components of the major
control region, some interesting questions regarding the relationship
between pathogenic V. cholerae strains and the kappa phage
family remain to be answered. Does phage K139 somehow contribute to the
fitness and pathogenicity of O1 V. cholerae cells? Also,
might K139 lysogeny support V. cholerae in its other, less
well investigated ecological niches, e.g., the seawater environment or
within shellfish?
 |
ACKNOWLEDGMENTS |
We thank I. B. Dodd, K. E. Klose, and J. Morschhäuser for many helpful comments, critical reading, and
suggestions. We also thank S. Kahn for expert help in protein
purification and A. Friedlein for mass spectroscopy analysis. For
clinical V. cholerae strains used in this study, we thank
J. J. Mekalanos and D. K. Karaolis.
This work was funded by BMBF grant 01KI8906.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Zentrum
für Infektionsforschung, Universität Würzburg,
Röntgenring 11, 97070 Würzburg, Germany. Phone: (49) (0)931
312153. Fax: (49) (0)931 312578. E-mail: joachim.reidl{at}rzroe.uni-wuerzburg.de.
 |
REFERENCES |
| 1.
|
Ackermann, H. W.,
S. S. Kasatiya,
T. Kawata,
T. Koga,
J. V. Lee,
A. Mbiguino,
F. S. Newman,
J. F. Vieu, and A. Zachary.
1984.
Classification of Vibrio bacteriophages.
Intervirology
22:61-71[Medline].
|
| 2.
|
Albert, J. B.,
A. K. Siddinque,
M. S. Islam,
A. S. G. Faruquwe,
M. Anzarzzaman,
S. M. Faruque, and R. Sack.
1993.
Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh.
Lancet
341:704[Medline].
|
| 3.
|
Altermann, E.,
J. R. Klein, and B. Henrich.
1998.
Synthesis and automated detection of fluorescently labeled primer extension products.
BioTechniques
26:96-98.
|
| 4.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 5.
|
Amman, E.,
B. Ochs, and K. Abel.
1988.
Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli.
Gene
69:301-315[Medline].
|
| 6.
|
Aono, R.,
N. Tsukagoshi, and N. Yamamoto.
1998.
Involvement of outer membrane protein TolC, a possible member of the mar-sox regulon, in maintenance and improvements of organic solvent tolerance of Escherichia coli.
J. Bacteriol.
180:938-944[Abstract/Free Full Text].
|
| 7.
|
Argos, P.,
A. Landy,
K. Abremski,
J. B. Egan,
E. Haggard-Ljungquist,
R. H. Hoess,
M. L. Kahn,
B. Kalionis,
S. V. Narayana,
L. S. Pierson III,
N. Sternberg, and J. M. Leong.
1986.
The integrase family of site-specific recombinases: regional similarities and global diversity.
EMBO J.
5:433-440[Medline].
|
| 8.
|
Barondess, J., and J. Beckwith.
1990.
A bacterial virulence determinant encoded by lysogenic coliphage lambda.
Nature
346:871-874[Medline].
|
| 9.
|
Basu, S., and S. Mukerjee.
1968.
Bacteriophage typing of Vibrio El-Tor.
Experientia
24:299-300[Medline].
|
| 10.
|
Bertani, L. E., and E. W. Six.
1988.
The P2-like phages and their parasite, P4, p. 73-143.
In
R. Calendar (ed.), The bacteriophages, 2nd ed. Plenum Press, New York, N.Y.
|
| 11.
|
Bradford, M. M.
1976.
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:248-254[Medline].
|
| 12.
|
Bradley, D. E.
1967.
Ultrastructure of bacteriophage and bacteriocins.
Bacteriol. Rev.
31:230-314[Free Full Text].
|
| 13.
|
Campbell, A. M.
1992.
Chromosomal insertion sites for phages and plasmids.
J. Bacteriol.
174:7495-7499[Free Full Text].
|
| 13a.
| Das, M., and A. K. Chopra, J. W. Peterson. 1997. Direct submission to GenBank.
|
| 14.
|
Decker, K.,
V. Kaul,
A. Meesmann, and K. J. Heller.
1994.
Lytic conversion of Escherichia coli by bacteriophage T5: blocking of the FhuA receptor protein by a lipoprotein expressed early during infection.
Mol. Microbiol.
12:321-332[Medline].
|
| 14a.
| Dodd, I. B. Personal communication.
|
| 15.
|
Dodd, I. B., and J. B. Egan.
1996.
DNA binding by the coliphage 186 repressor protein CI.
J. Biol. Chem.
271:11532-11540[Abstract/Free Full Text].
|
| 16.
|
Dodd, I. B., and J. B. Egan.
1990.
Improved detection of helix-turn-helix DNA binding motifs in protein sequences.
Nucleic Acids Res.
18:5019-5026[Abstract/Free Full Text].
|
| 17.
|
Esposito, D.,
W. P. Fitzmaurice,
R. C. Benjamin,
S. D. Goodman,
A. S. Waldman, and J. J. Scocca.
1996.
The complete nucleotide sequence of bacteriophage HP1 DNA.
Nucleic Acids Res.
24:2360-2368[Abstract/Free Full Text].
|
| 18.
|
Esposito, D., and J. J. Scocca.
1994.
Identification of an HP1 phage protein required for site-specific excision.
Mol. Microbiol.
13:685-695[Medline].
|
| 19.
|
Esposito, D.,
J. C. E. Wilson, and J. J. Scocca.
1997.
Reciprocal regulation of the early promoter region of bacteriophage HP1 by the Cox and CI proteins.
Virology
234:267-276[Medline].
|
| 20.
|
Gardel, C. L., and J. J. Mekalanos.
1996.
Alterations in Vibrio cholerae motility phenotypes correlate with changes in virulence factor expression.
Infect. Immun.
64:2246-2255[Abstract].
|
| 21.
|
Gerdes, J. C., and W. R. Romig.
1975.
Complete and defective bacteriophages of classical Vibrio cholerae: relationship to the kappa-type bacteriophage.
J. Virol.
15:1231-1238[Abstract/Free Full Text].
|
| 22.
|
Heinrich, J.,
M. Velleman, and H. Schuster.
1995.
The tripartite immunity system of phages P1 and P7.
FEMS Microbiol. Rev.
17:121-126[Medline].
|
| 23.
|
Higa, N.,
Y. Honma,
J. M. Albert, and M. Iwanaga.
1993.
Characterization of Vibrio cholerae O139 synonym Bengal isolated from patients with cholera-like disease in Bangladesh.
Microbiol. Immunol.
37:971-974[Medline].
|
| 24.
|
Hovde, C. J.,
S. B. Calderwood,
J. J. Mekalanos, and R. J. Collier.
1988.
Evidence that glutamic acid 167 is an active site residue of shiga-like toxin I.
Proc. Natl. Acad. Sci. USA
85:2568-2572[Abstract/Free Full Text].
|
| 25.
|
Johnson, A. D.,
A. R. Poteete,
G. Lauer,
R. T. Sauer,
G. K. Ackers, and M. Ptashne.
1981.
Lambda repressor and cro components of an efficient molecular switch.
Nature
294:217-223[Medline].
|
| 26.
|
Kalionis, B.,
I. B. Dodd, and J. B. Egan.
1986.
Control of gene expression in the P2-related template coliphages. III. DNA sequence of the major control region of phage 186.
J. Mol. Biol.
191:199-209[Medline].
|
| 27.
|
Karaolis, D. K.,
R. Lan, and P. R. Reeves.
1994.
Molecular evolution of the seventh-pandemic clone of Vibrio cholerae and its relationship to other pandemic and epidemic V. cholerae isolates.
J. Bacteriol.
176:6199-6206[Abstract/Free Full Text].
|
| 28.
|
Kliem, M., and B. Dreiseikelmann.
1989.
The superimmunity gene sim of bacteriophage P1 causes superinfection exclusion.
Virology
171:350-355[Medline].
|
| 29.
|
Klose, K. E., and J. J. Mekalanos.
1998.
Differential regulation of multiple flagellins in Vibrio cholerae.
J. Bacteriol.
180:303-316[Abstract/Free Full Text].
|
| 30.
|
Kraiß, A.,
S. Schloer, and J. Reidl.
1998.
In vivo transposon mutagenesis in Haemophilus influenzae.
Appl. Environ. Microbiol.
64:4697-4702[Abstract/Free Full Text].
|
| 31.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 32.
|
Lamont, I.,
H. Richardson,
D. R. Carter, and J. B. Egan.
1993.
Genes for the establishment and maintenance of lysogeny by the temperate coliphage 186.
J. Bacteriol.
175:5286-5288[Abstract/Free Full Text].
|
| 33.
|
Lee, J. V., and A. L. Furniss.
1981.
The phage typing of Vibrio cholerae serovar O1, p. 119-122.
In
T. Holme, J. Holmgren, M. H. Merson, and R. Molby (ed.), Acute enteric infections in children: new prospects for treatment and prevention. Elsevier/North Holland Biomedical Press, Amsterdam, The Netherlands.
|
| 34.
|
Lu, M. J., and U. Henning.
1994.
Superinfection exclusion by T-even-type coliphages.
Trends Microbiol.
2:137-139[Medline].
|
| 35.
|
Maillou, J., and B. Dreiseikelmann.
1990.
The sim gene of Escherichia coli phage P1: nucleotide sequence and purification of the processed protein.
Virology
175:500-507[Medline].
|
| 36.
|
Maniatis, T.,
E. F. Fritsch, and J. Sambrook.
1982.
Molecular cloning: a laboratory manual.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 37.
|
Mekalanos, J. J.
1983.
Duplication and amplification of toxin genes in Vibrio cholerae.
Cell
35:253-263[Medline].
|
| 38.
|
Miller, J. H.
1972.
Experiments in molecular genetics.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 39.
|
Mulligan, M. E.,
D. K. Hawley,
R. Entriken, and W. R. McClure.
1984.
E. coli promoter sequence predict in vitro RNA-polymerase selectivity.
Nucleic Acids Res.
12:789-797.
|
| 40.
|
Mullis, K. B., and F. Faloona.
1987.
Specific synthesis of DNA in vitro via a polymerase chain reaction.
Methods Enzymol.
155:335-340[Medline].
|
| 41.
|
Neely, M. N., and D. I. Friedman.
1998.
Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage function in toxin release.
Mol. Microbiol.
28:1255-1267[Medline].
|
| 42.
|
Neufing, P. J.,
K. E. Shearwin,
J. Camerotto, and J. B. Egan.
1996.
The CII protein of bacteriophage 186 establishes lysogeny by activating a promoter upstream of the lysogenic promoter.
Mol. Microbiol.
21:751-761[Medline].
|
| 43.
|
Neve, H.,
K. I. Zenz,
F. Desiere,
A. Koch,
K. J. Heller, and H. Brüssow.
1998.
Comparison of the lysogeny modules from the temperate Streptococcus thermophilus bacteriophages TP-J34 and Sfi21: implications for the modular theory of phage evolution.
Virology
241:61-72[Medline].
|
| 44.
|
Nicolle, P.,
J. Gallut, and M. F. Schraen.
1971.
Diversite des etats lysogenes parmi les vibrions choleriques El Tor de provenances varies.
Bull. Soc. Pathol. Exot.
604:603-612.
|
| 45.
|
Ramamurthy, T.,
S. Grag, and R. Sharma.
1993.
Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.
Lancet
341:703-704[Medline].
|
| 46.
|
Reed, M. R.,
K. E. Shearwin,
L. M. Pell, and J. B. Egan.
1997.
The dual role of Apl in prophage induction of coliphage 186.
Mol. Microbiol.
23:669-681[Medline].
|
| 47.
|
Reidl, J., and J. J. Mekalanos.
1995.
Characterization of Vibrio cholerae bacteriophage K139 and use of a novel mini transposon to identify a phage-encoded virulence factor.
Mol. Microbiol.
18:685-701[Medline].
|
| 48.
|
Rose, R. E.
1988.
The nucleotide sequence of pACYC177.
Nucleic Acids Res.
16:356[Free Full Text].
|
| 49.
|
Rose, R. E.
1988.
The nucleotide sequence of pACYC184.
Nucleic Acids Res.
16:356.
|
| 50.
|
Sanger, F.,
S. Nicklen, and A. R. Coulson.
1977.
DNA sequencing with chain-terminating inhibitors.
Proc. Natl. Acad. Sci. USA
74:5463-5467[Abstract/Free Full Text].
|
| 51.
|
Shimada, T.,
G. B. Nair,
B. C. Deb,
M. J. Albert,
R. B. Sack, and Y. Takeda.
1993.
Outbreak of Vibrio cholerae non-O1 in India and Bangladesh.
Lancet
341:1347[Medline].
|
| 52.
|
Shine, J., and L. Dalgarno.
1974.
The 3'-terminal sequence of Escherichia coli 16S ribosomal RNA: complementarity to nonsense triplets and ribosome binding sites.
Proc. Natl. Acad. Sci. USA
71:1341-1346.
|
| 53.
|
Silhavy, T. J.,
M. L. Berman, and L. W. Enquist.
1984.
Experiments with gene fusions.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 53a.
| Skowronek, K. 1996. Direct submission to GenBank.
|
| 54.
|
Susskind, M. M., and D. Botstein.
1978.
Molecular genetics of bacteriophage P22.
Microbiol. Rev.
42:385-413[Free Full Text].
|
| 55.
|
Susskind, M. M.,
A. Wright, and D. Botstein.
1971.
Superinfection exclusion by P22 prophage in lysogens of Salmonella typhimurium. II. Genetic evidence for two exclusion systems.
Virology
45:638-662[Medline].
|
| 56.
|
Synder, L.
1995.
Phage-exclusion enzymes: a bonanza of biochemical and cell biology reagents?
Mol. Microbiol.
15:415-420[Medline].
|
| 57.
|
Takeya, K., and S. Shimodori.
1963.
"Prophage typing" of El-Tor vibrios.
J. Bacteriol.
85:957-958[Free Full Text].
|
| 58.
|
Takeya, K.,
Y. Zinnaka,
S. Shimodori,
Y. Nakayama,
K. Amako, and K. Tida.
1965.
Lysogeny in El-Tor Vibrios, p. 24-29.
In
O. S. Bushnell, and C. S. Brookhyser (ed.), Proceedings of the Cholera Research Symposium, Honolulu. U.S. Department of Health, Education, and Welfare, Washington, D.C.
|
| 59.
|
Towbin, H.,
T. Staehelin, and J. Gordon.
1979.
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
Proc. Natl. Acad. Sci. USA
76:4350-4354[Abstract/Free Full Text].
|
| 60.
|
Trucksis, M.,
J. E. Galen,
J. Michalski,
A. Fasano, and J. B. Kaper.
1993.
Accessory cholera enterotoxin (Ace), the third toxin of Vibrio cholerae virulence cassette.
Proc. Natl. Acad. Sci. USA
90:5267-5271[Abstract/Free Full Text].
|
| 61.
|
von Gabain, A.,
J. G. Belasco,
J. L. Schottel,
A. C. Y. Chang, and S. N. Cohen.
1983.
Decay of mRNA in Escherichia coli: investigation of the fate of specific segments of transcripts.
Proc. Natl. Acad. Sci. USA
80:653-657[Abstract/Free Full Text].
|
| 62.
|
Vostrov, A. A.,
O. A. Vostrukhina,
A. N. Svarchevsky, and V. N. Rybchin.
1996.
Proteins responsible for lysogenic conversion caused by coliphages N15 and 80 are highly homologous.
J. Bacteriol.
178:1484-1486[Abstract/Free Full Text].
|
| 63.
|
Waldor, K. W., and J. J. Mekalanos.
1996.
Lysogenic conversion by a filamentous phage encoding cholera toxin.
Science
272:1910-1914[Abstract].
|
| 64.
|
Waldor, M. K., and J. J. Mekalanos.
1994.
ToxR regulates virulence gene expression in non-O1 strains of Vibrio cholerae that cause epidemic cholera.
Infect. Immun.
62:72-78[Abstract/Free Full Text].
|
| 65.
|
Watson, N.
1988.
A new revision of the sequence of plasmid pBR322.
Gene
70:399-403[Medline].
|
| 66.
|
Wright, A.
1971.
Mechanism of conversion of the Salmonella O antigen by bacteriophage 34.
J. Bacteriol.
105:927-936[Abstract/Free Full Text].
|
| 67.
|
Yu, A.,
L. E. Bertani, and E. Haggard-Ljungquist.
1989.
Control of prophage integration and excision in bacteriophage P2: nucleotide sequence of the int gene and att sites.
Gene
80:1-12[Medline].
|
Journal of Bacteriology, May 1999, p. 2902-2913, Vol. 181, No. 9
0021-9193/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Mahony, J., McGrath, S., Fitzgerald, G. F., van Sinderen, D.
(2008). Identification and Characterization of Lactococcal-Prophage-Carried Superinfection Exclusion Genes. Appl. Environ. Microbiol.
74: 6206-6215
[Abstract]
[Full Text]
-
Odegrip, R., Nilsson, A. S., Haggard-Ljungquist, E.
(2006). Identification of a Gene Encoding a Functional Reverse Transcriptase within a Highly Variable Locus in the P2-Like Coliphages. J. Bacteriol.
188: 1643-1647
[Abstract]
[Full Text]
-
Faruque, S. M., Naser, I. B., Islam, M. J., Faruque, A. S. G., Ghosh, A. N., Nair, G. B., Sack, D. A., Mekalanos, J. J.
(2005). Seasonal epidemics of cholera inversely correlate with the prevalence of environmental cholera phages. Proc. Natl. Acad. Sci. USA
102: 1702-1707
[Abstract]
[Full Text]
-
Clapper, B., Tu, A.-H. T., Elgavish, A., Dybvig, K.
(2004). The vir Gene of Bacteriophage MAV1 Confers Resistance to Phage Infection on Mycoplasma arthritidis. J. Bacteriol.
186: 5715-5720
[Abstract]
[Full Text]
-
Kapfhammer, D., Blass, J., Evers, S., Reidl, J.
(2002). Vibrio cholerae Phage K139: Complete Genome Sequence and Comparative Genomics of Related Phages. J. Bacteriol.
184: 6592-6601
[Abstract]
[Full Text]
-
Nesper, J., Schild, S., Lauriano, C. M., Kraiss, A., Klose, K. E., Reidl, J.
(2002). Role of Vibrio cholerae O139 Surface Polysaccharides in Intestinal Colonization. Infect. Immun.
70: 5990-5996
[Abstract]
[Full Text]
-
de la Fuente, J., Garcia-Garcia, J. C., Blouin, E. F., Saliki, J. T., Kocan, K. M.
(2002). Infection of Tick Cells and Bovine Erythrocytes with One Genotype of the Intracellular Ehrlichia Anaplasma marginale Excludes Infection with Other Genotypes. CVI
9: 658-668
[Abstract]
[Full Text]
-
Shearwin, K. E., Dodd, I. B., Egan, J. B.
(2002). The Helix-Turn-Helix Motif of the Coliphage 186 Immunity Repressor Binds to Two Distinct Recognition Sequences. J. Biol. Chem.
277: 3186-3194
[Abstract]
[Full Text]
-
Lewis, J. A., Hatfull, G. F.
(2001). Control of directionality in integrase-mediated recombination: examination of recombination directionality factors (RDFs) including Xis and Cox proteins. Nucleic Acids Res
29: 2205-2216
[Abstract]
[Full Text]
-
Nesper, J., Lauriano, C. M., Klose, K. E., Kapfhammer, D., Krai{beta}, A., Reidl, J.
(2001). Characterization of Vibrio cholerae O1 El Tor galU and galE Mutants: Influence on Lipopolysaccharide Structure, Colonization, and Biofilm Formation. Infect. Immun.
69: 435-445
[Abstract]
[Full Text]
-
Nesper, J., Kapfhammer, D., Klose, K. E., Merkert, H., Reidl, J.
(2000). Characterization of Vibrio cholerae O1 Antigen as the Bacteriophage K139 Receptor and Identification of IS1004 Insertions Aborting O1 Antigen Biosynthesis. J. Bacteriol.
182: 5097-5104
[Abstract]
[Full Text]